Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 19:14:1228377.
doi: 10.3389/fneur.2023.1228377. eCollection 2023.

Comorbidity and polypharmacy impact neurobehavioral symptoms and symptom validity failure among post-9/11 veterans with mild traumatic brain injury

Affiliations

Comorbidity and polypharmacy impact neurobehavioral symptoms and symptom validity failure among post-9/11 veterans with mild traumatic brain injury

Alicia A Swan et al. Front Neurol. .

Abstract

Objective: The study aimed to examine the association between post-concussive comorbidity burdens [post-traumatic stress disorder (PTSD), depression, and/or headache] and central nervous system (CNS) polypharmacy (five or more concurrent medications) with reported neurobehavioral symptoms and symptom validity screening among post-9/11 veterans with a history of mild traumatic brain injury (mTBI).

Setting: Administrative medical record data from the Department of Veterans Affairs (VA) were used in the study.

Participants: Post-9/11 veterans with mTBI and at least 2 years of VA care between 2001 and 2019 who had completed the comprehensive traumatic brain injury evaluation (CTBIE) were included in the study.

Design: Retrospective cross-sectional design was used in the study.

Main measures: Neurobehavioral Symptom Inventory (NSI), International Classification of Diseases, Ninth Revision, and Clinical Modification diagnosis codes were included in the study.

Results: Of the 92,495 veterans with a history of TBI, 90% had diagnoses of at least one identified comorbidity (PTSD, depression, and/or headache) and 28% had evidence of CNS polypharmacy. Neurobehavioral symptom reporting and symptom validity failure was associated with comorbidity burden and polypharmacy after adjusting for sociodemographic characteristics. Veterans with concurrent diagnoses of PTSD, depression, and headache were more than six times more likely [Adjusted odds ratio = 6.55 (99% CI: 5.41, 7.92)]. to fail the embedded symptom validity measure (Validity-10) in the NSI.

Conclusion: TBI-related multimorbidity and CNS polypharmacy had the strongest association with neurobehavioral symptom distress, even after accounting for injury and sociodemographic characteristics. Given the regular use of the NSI in clinical and research settings, these findings emphasize the need for comprehensive neuropsychological evaluation for individuals who screen positively for potential symptom overreporting, the importance of multidisciplinary rehabilitation to restore functioning following mTBI, and the conscientious utilization of symptom validity measures in research efforts.

Keywords: concussion; headache; multimorbidity; polypharmacy; post-traumatic stress disorders; veterans.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

References

    1. DOD TBI Worldwide Numbers . Military Health System. Available online at: https://armymedicine.health.mil/MHSHome/Military-Health-Topics/Centers-o... (accessed December 29, 2022).
    1. Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J Neurotrauma. (2010) 27:1529–40. 10.1089/neu.2010.1358 - DOI - PubMed
    1. Pugh MJ, Swan AA, Amuan ME, Eapen BC, Jaramillo CA, Delgado R, et al. . Deployment, suicide, and overdose among comorbidity phenotypes following mild traumatic brain injury: a retrospective cohort study from the Chronic Effects of Neurotrauma Consortium Agarwal S, editor. PLoS ONE. (2019) 14:e0222674. 10.1371/journal.pone.0222674 - DOI - PMC - PubMed
    1. Brown-Taylor L, Jaramillo C, Eapen BC, Kretzmer T, Gavin LP, Cooper T, et al. . Accumulation of good intentions: how individual practice guidelines lead to polypharmacy in the treatment of patients with polytrauma. PM&R. (2021) 13:1169–75. 10.1002/pmrj.12526 - DOI - PubMed
    1. Eide RP, Stahlman S. Polypharmacy involving opioid, psychotropic, and central nervous system depressant medications, period prevalence and association with suicidal ideation, active component, U.S. Armed Forces, 2016. MSMR. (2018) 25:2–9. - PubMed

LinkOut - more resources